title: Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Mishkin
authors.forename: William
authors.initials: W
authors.lastname: Van Deinse
authors.forename: James M
authors.initials: JM
authors.lastname: Becker
authors.forename: Francis A
authors.initials: FA
authors.lastname: Farraye
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D012074:Remission Induction; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab